1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. TANGO THERAPEUTICS INC
Tango Therapeutics Inc
XNAS: TNGX
20.88 -3.99 (-16.04%)
1.6M
XNAS Volume

XNAS 15 May, 2026 10:29 AM (EDT)

Watchlist

Portfolio

Alert

Analyst Downgrade
Jefferies downgrades Tango Therapeutics to a 'Hold' rating; cites valuation concerns See details

Tango Therapeutics Inc - TNGX - stock price prediction, stock price target, analyst ratings from 12 analysts

Tango Therapeutics Inc has a share price target of US$ 33, revenue growth forecast of -94.4%, and profit growth estimate of -91.3% for FY27, based on top 12 analyst calls.